1998
DOI: 10.1016/s0923-2494(98)80009-6
|View full text |Cite
|
Sign up to set email alerts
|

The use of oxygen carriers for increasing the production of monoclonal antibodies from hollow fibre bioreactors

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
7
0

Year Published

2001
2001
2016
2016

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 12 publications
(7 citation statements)
references
References 15 publications
0
7
0
Order By: Relevance
“…7,8 The use of O 2 carriers in the cell culture system, on the other hand, provides a biomimetic approach to recapitulate the in vivo oxygenation environment for many tissue engineering applications. [9][10][11] In particular, hepatic hollow fiber (HF) bioreactors that constitute one type of bioartificial liver assist device (BLAD) suffer from O 2 limited transport mainly due to the low solubility of O 2 in the cell culture medium, long diffusion pathlengths, and high demand for O 2 by the hepatocytes cultured in the extracapillary space (ECS). [12][13][14] These devices are expected to bridge patients suffering from acute liver failure toward native liver regeneration or orthotopic liver transplantation by providing sufficient global liver functions.…”
Section: Introductionmentioning
confidence: 99%
“…7,8 The use of O 2 carriers in the cell culture system, on the other hand, provides a biomimetic approach to recapitulate the in vivo oxygenation environment for many tissue engineering applications. [9][10][11] In particular, hepatic hollow fiber (HF) bioreactors that constitute one type of bioartificial liver assist device (BLAD) suffer from O 2 limited transport mainly due to the low solubility of O 2 in the cell culture medium, long diffusion pathlengths, and high demand for O 2 by the hepatocytes cultured in the extracapillary space (ECS). [12][13][14] These devices are expected to bridge patients suffering from acute liver failure toward native liver regeneration or orthotopic liver transplantation by providing sufficient global liver functions.…”
Section: Introductionmentioning
confidence: 99%
“…The application of the PFD-mediated oxygenation system in Nicotiana tabacum BY-2 (Bright Yellow 2) cultures performed in a hollow-fibre bioreactor has resulted in 1.1 time k L a increase, as well as up to 5 times higher biomass yield in comparison to the culture system utilising atmospheric air as oxygenation medium (Pilarek et al, 2009). A hollow-fibre bioreactor has been also utilised for monoclonal antibody (mAb) production in cultures of mouse 3C11 hybridoma cells (Shi et al, 1998). The application of aerated Oxyfluor emulsion as an oxygenation agent has resulted in a 78 % increase in yield of IG 1 -type mAbs.…”
Section: Pfc-mediated Oxygen Transfer Intensificationmentioning
confidence: 99%
“…Therefore, the LEH of the existing design cannot be used as an oxygen carrier to precursor liver tissue where we need to grow hepatocyte progenitors. Hbbased oxygen carrier is ideal, but as shown in the study of Shi et al who observed strong toxicity of free Hb when it is directly added to cell culture with over 1% concentrations [112].…”
Section: Hemoglobin (Hb)-based Oxygen Carriersmentioning
confidence: 99%